DiaMedica Therapeutics, Inc. (DMAC)
6.35
+0.03
(+0.47%)
USD |
NASDAQ |
May 11, 14:47
DiaMedica Therapeutics Total Liabilities (Quarterly) : 5.845M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| IN8bio, Inc. | 3.484M |
| Calidi Biotherapeutics, Inc. | 5.098M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Amgen, Inc. | 83.31B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 53.08M |
| Shareholders Equity (Quarterly) | 47.24M |
| Debt to Equity Ratio | 0.0045 |
| Current Ratio | 9.110 |
| Net Debt Paydown Yield | 0.01% |